碧桂園(02007.HK)指盈警影響因素多為非現金性質 對集團發展充滿信心
碧桂園(02007.HK)發盈警,預期去年度可能錄得剔除公允價值變動、匯兌淨損益等影響後的歸屬於公司股東的核心淨利潤介乎約10億至30億元人民幣(下同),及股東應佔虧損介乎約55億至75億元;而2021年同期錄得核心淨利潤約269億元及股東應佔利潤約268億元。
公司指出,上述盈利的影響因素多為非現金性質。房地產仍是中國經濟的支柱產業之一,公司定能抓住市場修復的機遇,踐行新的發展模式,繼續走高質量發展之路,並結合科技建造體系,持續提升全周期綜合競爭力。公司對集團的發展充滿信心。
此外,公司已先後與數十家銀行簽署戰略合作協議,獲得逾3,000億元人民幣意向性綜合授信支持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.